TherapeuticsMD, Inc. (NASDAQ:TXMD – Get Rating) major shareholder Rubric Capital Management Lp purchased 17,688 shares of the firm’s stock in a transaction dated Monday, July 18th. The stock was acquired at an average cost of $6.03 per share, for a total transaction of $106,658.64. Following the completion of the purchase, the insider now owns 1,156,953 […]
